Published in Blood Weekly, October 7th, 2004
The technology was licensed from MEDOS Medizintechnik AG in Stolberg, Germany. MEDOS is a developer of driver systems and ventricular assist devices and other circulatory support devices.
The new driver, a console that pulses pressurized air and monitors pump function, is a fraction of the size of the original driver. This driver will allow patients greater mobility leading to a speedier recovery and improved patient spirits. Outside of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-10-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.